OOIR: Observatory of International Research

Papers

(The H4-Index of Heart is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people	274
Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis	186
COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?	154
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19	150
Place and causes of acute cardiovascular mortality during the COVID-19 pandemic	139
Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis	118
Prevalence, incidence and survival of heart failure: a systematic review	96
Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China	96
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure	91
Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK	89
Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management	83
Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction	77
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19	76
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis	75
Diagnosis, management and therapeutic strategies for congenital long QT syndrome	75
Excess of cardiovascular deaths during the COVID-19 pandemic in Brazilian capital cities	73
Atrial fibrillation and the prothrombotic state: revisiting Virchow’s triad in 2020	69
Multimodality imaging assessment of mitral annular disjunction in mitral valve prolapse	63
Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank	62
Recent advances in percutaneous coronary intervention	58
Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis	56
Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 2017	56
Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges	54
Arrhythmogenic left ventricular cardiomyopathy	53
Global longitudinal strain: clinical use and prognostic implications in contemporary practice	52

Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation	50
Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure	47
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry	47
Adult congenital heart disease and the COVID-19 pandemic	46
Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis	46
Pregnancy in congenital heart disease: risk prediction and counselling	45
Longitudinal associations between loneliness, social isolation and cardiovascular events	44
Systematic review of current natural language processing methods and applications in cardiology	43
Cardiac sarcoidosis: state-of-the-art review	42
Maternal cardiovascular risk after hypertensive disorder of pregnancy	42
Cardiotoxicities of novel cancer immunotherapies	41
Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China	41
Eisenmenger syndrome: diagnosis, prognosis and clinical management	40
Sex differences in the association between childhood maltreatment and cardiovascular disease in the UK Biobank	39
Limit of detection of troponin discharge strategy versus usual care: randomised controlled trial	39
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis	39